# NITROFURANTOIN
> **ANDA218346** · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2024-10-28
## Drug
- **FDA Application Number:** ANDA218346
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NITROFURANTOIN
- **Generic name:** NITROFURANTOIN
- **Active ingredients:** NITROFURANTOIN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BIOCON PHARMA
- **Manufacturer:** Biocon Pharma Inc
- **First approval:** 2024-10-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218346)
---
*MORVS · CC0 1.0*